- 期刊
Heterogeneity in Multiple Sclerosis: Scratching the Surface of a Complex Disease
延伸閱讀
- Kawamoto, E., Nakahashi, S., Okamoto, T., Imai, H., & Shimaoka, M. (2012). Anti-Integrin Therapy for Multiple Sclerosis. Autoimmune Diseases, 2012(), 163-168. https://doi.org/10.1155/2012/357101
- Bermel, R., Waldman, A., & Mowry, E. M. (2014). Outcome Measures in Multiple Sclerosis. Multiple Sclerosis International, (2014), 92-93. https://doi.org/10.1155/2014/439375
- Pena, J. A., & Lotze, T. E. (2013). Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions. Autoimmune Diseases, 2013(), 132-143. https://doi.org/10.1155/2013/673947
- Finkelsztejn, A. (2014). Multiple Sclerosis: Overview of Disease-Modifying Agents. Perspectives in Medicinal Chemistry, (2014), 65-72. https://doi.org/10.4137/PMC.S13213
- Anagnostouli, S. K. A. M. (2013). Biomarkers in Multiple Sclerosis: An Up-to-Date Overview. Multiple Sclerosis International, 2013(), 95-114. https://doi.org/10.1155/2013/340508